Are peptides legal in Australia?
Sourced guide to the legal status of peptides in Australia, refreshed automatically from live research.
Overall Status: Restricted
Short answer: Peptides such as BPC-157, TB-500, semaglutide-class GLP-1s, and HGH are restricted in Australia, where the Therapeutic Goods Administration (TGA) requires them to be either an approved, ARTG-listed prescription medicine or a pharmacist-compounded preparation dispensed against a valid doctor's prescription before they can be lawfully supplied.
Important: This information is for educational purposes only and does not constitute legal advice. Laws and enforcement policies change. Consult a qualified attorney for specific legal guidance.
Overview
Peptides are restricted, not freely legal, in Australia. The Therapeutic Goods Administration (TGA) regulates any product intended for therapeutic use under the Therapeutic Goods Act 1989, and products generally must be entered on the Australian Register of Therapeutic Goods (ARTG) before lawful supply unless a specific exemption applies, such as a pharmacist compounding a preparation for a named patient under prescription. Separately, the national Poisons Standard sets scheduling classifications (adopted into state and territory law) that place substances like human growth hormone into Schedule 4, Prescription Only Medicine, meaning supply without a prescription is unlawful. Peptides like BPC-157 and TB-500 are not ARTG-approved products, so they cannot be lawfully marketed directly to consumers, and are generally only accessed through a doctor's prescription filled by a compounding pharmacy.
Key Points
- The Therapeutic Goods Administration (TGA) regulates peptides in Australia under the Therapeutic Goods Act 1989, and products intended for therapeutic use generally must be entered on the Australian Register of Therapeutic Goods (ARTG) before they can be lawfully supplied. [3]
- The national Poisons Standard, which Australian states and territories adopt into their own drugs-and-poisons legislation, classifies substances such as human growth hormone and various growth-hormone-related peptides as Schedule 4 Prescription Only Medicines, meaning they cannot be lawfully supplied without a valid prescription. [2]
- Peptides such as BPC-157 and TB-500 are not ARTG-approved therapeutic goods in Australia, so companies cannot lawfully market or sell them directly to consumers as human-use products outside the prescription/compounding pathway. [3]
- Individuals can personally import a limited supply of certain medicines into Australia under the TGA's Personal Importation Scheme, but this generally requires the traveller to carry a valid prescription or equivalent evidence and to stay within a limited personal-use quantity. [4]
- Unapproved peptides imported into Australia without a prescription and without ARTG approval can be treated as prohibited or restricted imports and are subject to seizure at the border, though the specific enforcement details for individual travellers vary by product. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- No independently verified TGA enforcement action or specific 2023-2025 regulatory change targeting named research peptides (e.g. BPC-157, TB-500) could be confirmed in this research session due to a search-tool access limitation, so readers should check the TGA's own site directly for the most current scheduling decisions and safety alerts on peptides. (No reliable source found for this point -- flagged as unverified rather than stated as fact.)
- Selling unapproved peptides for human therapeutic use in Australia without ARTG inclusion or a valid prescription/compounding pathway can expose a supplier to penalties under the Therapeutic Goods Act 1989's general prohibition on supplying goods that are not included on the ARTG when required. [3]
Peptide-by-peptide status in Australia
| BPC-157 | BPC-157 is not an ARTG-approved therapeutic good in Australia, so it cannot be lawfully sold direct-to-consumer for human use and is generally only available through a doctor's prescription dispensed by a compounding pharmacy for a specific patient. [3] |
|---|
| TB-500 | TB-500 is not listed on Australia's ARTG, meaning unauthorised online sale for human use is not a recognised lawful supply channel and lawful access, where available, would similarly depend on a prescription-based compounding pathway. [3] |
|---|
| Semaglutide (Ozempic/Wegovy) and related GLP-1 peptides | Semaglutide is lawfully available in Australia only as a Schedule 4 Prescription Only Medicine when supplied as an ARTG-approved product such as Ozempic or Wegovy, or as a pharmacist-compounded version dispensed against a doctor's prescription. [2] |
|---|
| Human Growth Hormone (HGH/somatropin) | Human growth hormone is classified as a Schedule 4 Prescription Only Medicine in Australia, so supplying or possessing it without a valid prescription is unlawful under state and territory drugs-and-poisons legislation implementing the national Poisons Standard. [2] |
|---|
Last researched: 2026-09-10
Frequently asked questions
No, peptides such as BPC-157 cannot be lawfully bought in Australia without a prescription, because they are not ARTG-approved therapeutic goods and the only recognised lawful pathway is a doctor's prescription filled by a compounding pharmacy for that specific patient.
[3]
Personal importation of peptides into Australia is only supported under the TGA's Personal Importation Scheme when the traveller holds a valid prescription and stays within a limited personal-use quantity; unapproved peptides brought in without a prescription risk being seized at the border.
[4]
An Australian-registered doctor, including via telehealth, can prescribe peptides such as semaglutide where clinically appropriate and have them dispensed through a licensed pharmacy, but no verified source could confirm the specific extent of telehealth prescribing practice for peptides like BPC-157 in this research session.
Selling unapproved research peptides for human use in Australia without ARTG approval breaches the Therapeutic Goods Act 1989's supply requirements, which can expose the supplier to regulatory and legal consequences, though specific recent penalty cases could not be independently verified in this session.
[3]
Human growth hormone is not legal to buy over the counter in Australia because it is a Schedule 4 Prescription Only Medicine, so it can only be lawfully supplied against a valid prescription from an authorised medical practitioner.
[2]